Yongsheng Wang

Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer

You Lü, Jianxin Xue, Tao Deng et al. · Nature Medicine · 2020 · 537 citations

Life Sciences, Biotechnology, Oncology +14

A Tumor-selective Biotherapy With Prolonged Impact on Established Metastases Based on Cytokine Gene-engineered MSCs

Xiancheng Chen, Xiaojuan Lin, Jianlei Zhao et al. · Molecular Therapy · 2008 · 178 citations · Full text

Medicine, Immunology, Oncology +17

Ivonescimab Plus Chemotherapy in Non–Small Cell Lung Cancer With <i>EGFR</i> Variant

Wen‐Feng Fang, Yuanyuan Zhao, Yongzhong Luo et al. · JAMA · 2024 · 168 citations · Full text

Medicine, Oncology, Pharmacology +16

Datopotamab Deruxtecan Versus Chemotherapy in Previously Treated Inoperable/Metastatic Hormone Receptor–Positive Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer: Primary Results From TROPION-Breast01

Aditya Bardia, Komal Jhaveri, Seock‐Ah Im et al. · Journal of Clinical Oncology · 2024 · 140 citations · Full text

Medicine, Oncology, Pharmacology +17

Silencing of <i>pkm2</i> increases the efficacy of docetaxel in human lung cancer xenografts in mice

Dan Li, Jing Zhang, Yongsheng Wang et al. · Cancer Science · 2010 · 112 citations · Full text

Medicine, Oncology, Pharmacology +17